Kaseya Connect 2018 Pulls Out All the Stops for Annual User Conference
Mar 26, 2018 11:00 am UTC| Business
NEW YORK and MIAMI, March 26, 2018 -- Kaseya®, the leading provider of complete IT management solutions for managed service providers (MSPs) and mid-market enterprises (MME), today announced an exciting line-up of...
Mar 26, 2018 11:00 am UTC| Business
DEVON, Pa., March 26, 2018 -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty neuropsychiatric pharmaceutical company dedicated to developing and commercializing innovative...
Axsome Therapeutics to Present at H.C. Wainwright Annual Global Life Sciences Conference
Mar 26, 2018 11:00 am UTC| Business
NEW YORK, March 26, 2018 -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, today announced...
Apricus Biosciences Announces Scheduling of Vitaros™ End-of-Review Meeting with FDA
Mar 26, 2018 11:00 am UTC| Business
SAN DIEGO, March 26, 2018 -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that its end-of-review meeting with the U.S....
Global Health and Wellness Tourism Market 2018: Wellness Tourism is Growing at 12% Per Year
Mar 26, 2018 10:52 am UTC| Business
Dublin, March 26, 2018 -- The "Global Health and Wellness Tourism 2018" report has been added to ResearchAndMarkets.com's offering. Global Health and Wellness Tourism 2018 examines the global...
Global Molecular Diagnostics for Infectious Disease Markets 2018-2019 & 2023
Mar 26, 2018 10:47 am UTC| Business
Dublin, March 26, 2018 -- The "Global Molecular Diagnostics for Infectious Disease 2019 to 2023 - Markets, Strategies and Trends, Volume Price Forecasts by Pathogen and by Country" report has been added to ...
Mar 26, 2018 10:45 am UTC| Business
STAMFORD, Conn., March 26, 2018 -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, today announced...